RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 43 filers reported holding RELMADA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,687 | +8.6% | 115,229 | -11.0% | 0.00% | – |
| Q2 2023 | $318,395 | -74.4% | 129,429 | -76.5% | 0.00% | – |
| Q1 2023 | $1,245,477 | -64.0% | 551,096 | -44.4% | 0.00% | – |
| Q4 2022 | $3,460,216 | -84.2% | 991,466 | +68.0% | 0.00% | -100.0% |
| Q3 2022 | $21,847,000 | +91.4% | 590,134 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $11,417,000 | -5.1% | 601,185 | +34.9% | 0.00% | 0.0% |
| Q1 2022 | $12,026,000 | +65.1% | 445,564 | +37.8% | 0.00% | – |
| Q4 2021 | $7,286,000 | -14.7% | 323,401 | -0.8% | 0.00% | – |
| Q3 2021 | $8,541,000 | -14.0% | 325,871 | +5.1% | 0.00% | -100.0% |
| Q2 2021 | $9,928,000 | -3.0% | 310,164 | +6.7% | 0.00% | 0.0% |
| Q1 2021 | $10,231,000 | +4.8% | 290,585 | -4.6% | 0.00% | 0.0% |
| Q4 2020 | $9,764,000 | -14.1% | 304,459 | +0.7% | 0.00% | 0.0% |
| Q3 2020 | $11,373,000 | -10.8% | 302,321 | +6.2% | 0.00% | 0.0% |
| Q2 2020 | $12,744,000 | +4340.4% | 284,771 | +3290.1% | 0.00% | – |
| Q1 2020 | $287,000 | – | 8,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 111,550 | $274,413 | 0.39% |
| Deep Track Capital, LP | 2,837,818 | $6,981,032 | 0.32% |
| apricus wealth, LLC | 77,329 | $219,614 | 0.19% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 873,312 | $2,148,348 | 0.16% |
| Palo Alto Investors LP | 732,400 | $1,801,704 | 0.15% |
| RTW INVESTMENTS, LP | 2,131,835 | $5,244,314 | 0.10% |
| AdvisorShares Investments LLC | 112,898 | $277,729 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 271,524 | $668 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $49,200 | 0.04% |
| Savior LLC | 3,500 | $8,610 | 0.04% |